Search Results - "Nüesch, E."

Refine Results
  1. 1

    Alectinib versus crizotinib in treatment-naive anaplastic lymphoma kinase-positive (ALK+) non-small-cell lung cancer: CNS efficacy results from the ALEX study by Gadgeel, S., Peters, S., Mok, T., Shaw, A.T., Kim, D.W., Ou, S.I., Pérol, M., Wrona, A., Novello, S., Rosell, R., Zeaiter, A., Liu, T., Nüesch, E., Balas, B., Camidge, D.R.

    Published in Annals of oncology (01-11-2018)
    “…The phase III ALEX study in patients with treatment-naive advanced anaplastic lymphoma kinase mutation-positive (ALK+) non-small-cell lung cancer (NSCLC) met…”
    Get full text
    Journal Article
  2. 2

    A real-world study of cardiac events in > 3700 patients with HER2-positive early breast cancer treated with trastuzumab: final analysis of the OHERA study by Lidbrink, Elisabet, Chmielowska, E., Otremba, B., Bouhlel, A., Lauer, S., Liste Hermoso, M., Nüesch, E., Shing, M., Misra, V.

    Published in Breast cancer research and treatment (01-02-2019)
    “…Purpose Cardiac dysfunction risk associated with intravenous trastuzumab (H IV) treatment may differ in real-world practice versus randomized trials. We…”
    Get full text
    Journal Article
  3. 3

    The prevalence of widespread central hypersensitivity in chronic pain patients by Schliessbach, J., Siegenthaler, A., Streitberger, K., Eichenberger, U., Nüesch, E., Jüni, P., Arendt-Nielsen, L., Curatolo, M.

    Published in European journal of pain (01-11-2013)
    “…Background Chronic pain is associated with generalized hypersensitivity and impaired endogenous pain modulation (conditioned pain modulation; CPM). Despite…”
    Get full text
    Journal Article
  4. 4

    Effects of erythropoiesis-stimulating agents on fatigue- and anaemia-related symptoms in cancer patients: systematic review and meta-analyses of published and unpublished data by Bohlius, J, Tonia, T, Nüesch, E, Jüni, P, Fey, M F, Egger, M, Bernhard, J

    Published in British journal of cancer (08-07-2014)
    “…Background: Erythropoiesis-stimulating agents (ESAs) reduce the need for red blood cell transfusions; however, they increase the risk of thromboembolic events…”
    Get full text
    Journal Article
  5. 5

    Prevalence of cam and pincer-type deformities on hip MRI in an asymptomatic young Swiss female population: a cross-sectional study by Leunig, M, Jüni, P, Werlen, S, Limacher, A, Nüesch, E, Pfirrmann, C.W, Trelle, S, Odermatt, A, Hofstetter, W, Ganz, R, Reichenbach, S

    Published in Osteoarthritis and cartilage (01-04-2013)
    “…Summary Objectives Femoroacetabular impingement is proposed to cause early osteoarthritis (OA) in the non-dysplastic hip. We previously reported on the…”
    Get full text
    Journal Article
  6. 6

    Integrating fragmented evidence by network meta-analysis: relative effectiveness of psychological interventions for adults with post-traumatic stress disorder by Gerger, H, Munder, T, Gemperli, A, Nüesch, E, Trelle, S, Jüni, P, Barth, J

    Published in Psychological medicine (01-11-2014)
    “…To summarize the available evidence on the effectiveness of psychological interventions for patients with post-traumatic stress disorder (PTSD). We searched…”
    Get more information
    Journal Article
  7. 7

    A randomised controlled trial of spinal manipulative therapy in acute low back pain by Jüni, P, Battaglia, M, Nüesch, E, Hämmerle, G, Eser, P, van Beers, R, Vils, D, Bernhard, J, Ziswiler, H-R, Dähler, M, Reichenbach, S, Villiger, P M

    Published in Annals of the rheumatic diseases (01-09-2009)
    “…To determine whether treatment with spinal manipulative therapy (SMT) administered in addition to standard care is associated with clinically relevant early…”
    Get more information
    Journal Article
  8. 8
  9. 9

    Treatment failure in pneumonia: impact of antibiotic treatment and cost analysis by OTT, S. R, HAUPTMEIER, B. M, ERNEN, C, LEPPER, P. M, NÜESCH, E, PLETZ, M. W, HECHT, J, WELTE, T, BAUER, T. T

    Published in The European respiratory journal (01-03-2012)
    “…The aim of this study was to investigate treatment failure (TF) in hospitalised community-acquired pneumonia (CAP) patients with regard to initial antibiotic…”
    Get full text
    Journal Article
  10. 10

    An examination chair to measure internal rotation of the hip in routine settings: a validation study by Reichenbach, S, Jüni, P, Nüesch, E, Frey, F, Ganz, R, Leunig, M

    Published in Osteoarthritis and cartilage (01-03-2010)
    “…Summary Objective To determine the performance of a newly developed examination chair as compared with the clinical standard of assessing internal rotation…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    The effects of excluding patients from the analysis in randomised controlled trials: meta-epidemiological study by Nüesch, Eveline, Trelle, Sven, Reichenbach, Stephan, Rutjes, Anne W S, Bürgi, Elizabeth, Scherer, Martin, Altman, Douglas G, Jüni, Peter

    Published in BMJ (07-09-2009)
    “…Objective To examine whether excluding patients from the analysis of randomised trials are associated with biased estimates of treatment effects and higher…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Pharmacokinetics of SMS 201-995 in healthy subjects by Kutz, K, Nüesch, E, Rosenthaler, J

    “…The pharmacokinetics of a new somatostatin derivative, SMS 201-995, was investigated in a group of eight healthy subjects. SMS 201-995 was given intravenously…”
    Get more information
    Journal Article
  18. 18

    Abstract P6-17-30: Changes in patient, tumor, and treatment characteristics over time in first-line trastuzumab plus taxane (paclitaxel/docetaxel) arms in HER2-positive metastatic breast cancer trials by Badovinac Crnjevic, T, Restuccia, E, Michielin, F, Eng-Wong, J, Nüesch, E

    Published in Cancer research (Chicago, Ill.) (15-02-2019)
    “…Background: A retrospective analysis showed improved progression-free survival and consistent underestimation of trastuzumab (H) + taxane (T) efficacy…”
    Get full text
    Journal Article
  19. 19
  20. 20